Evidence map›Paper›PMID 34765190›Full record

ArticleBiomedical reports2021

Mitochondria-related TFAM gene variants and their effects on patients with cervical cancer.

Ieva Golubickaite, Rasa Ugenskiene, Juste Cepaite, Egle Ziliene, Arturas Inciura, Lina Poskiene, Elona Juozaityte

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedical reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Mitochondrial function meets oncology: the multifaceted role of TFAM across cancer types.Apoptosis : an international journal on programmed cell death · 2026
    Review
  2. Mitochondria transcription and cancer.Cell death discovery · 2024
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ieva GolubickaiteDepartment of Genetics and Molecular Medicine, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
Rasa UgenskieneDepartment of Genetics and Molecular Medicine, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
Juste CepaiteInstitute of Oncology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
Egle ZilieneInstitute of Oncology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
Arturas InciuraInstitute of Oncology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
Lina PoskieneDepartment of Pathological Anatomy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
Elona JuozaityteInstitute of Oncology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer is the fourth most common type of cancer in women worldwide, with high incidence and mortality rates, particularly in developing countries. There are human papillomavirus vaccines and cytological screening programs available; however, there are no molecular markers that would aid the prognosis of the course of the disease or prediction of the outcomes of the patients. The aim of the present study was to investigate the associations between single nucleotide polymorphisms (SNPs) of the mitochondrial transcription factor A (

Indexed as

cervical cancermitochondrial transcription factor Asingle nucleotide polymorphismtumor phenotype

Identifiers

PMID34765190
PMCPMC8576402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.